The National Pharmaceutical Pricing Authority (NPPA) has requested data on prices to retailers and annual turnover from ...

SHOPPING: Adding to their repertoire of undupable formulas, Charlotte Tilbury unveils five new, ultra-blendable shades of the ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the ...

In a Jan. 10 precedential ruling by the United States Court of Appeals for the Federal Circuit, the validity of the U.S. patent covering ...

The FDA has accepted the BLA for lecanemab-irmb SC for weekly maintenance dosing in the treatment of early Alzheimer disease.

Prostate health is a crucial aspect of well-being for men, especially as they age. With increasing concerns surrounding ...

In today’s fast-paced world, achieving weight loss goals can often feel overwhelming. With countless options available on the ...

In the world of male enhancement supplements, Blood Flow Titan Pro has emerged as a notable competitor, capturing the ...

Sudarshan and Emerge inked a three-year R&D partnership agreement. The joint venture is expected to begin operations in 2025 ...

Jubilant Pharmova said that the solid oral formulations facility of its subsidiary Jubilant Cadista Pharmaceuticals Inc., which is located at Salisbury, Maryland, USA, has received five observations ...

It said going forward, the facility will not manufacture any products as it had closed manufacturing operations, which was ...

ONS-5010 is an investigational ophthalmic formulation of bevacizumab, a vascular endothelial growth factor inhibitor, under development as an intravitreal injection.